These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25188466)

  • 1. Improved adverse postoperative outcomes with revised American College of Cardiology/American Heart Association guidelines for patients with cardiac stents.
    Graham LA; Singletary BA; Richman JS; Maddox TM; Itani KM; Hawn MT
    JAMA Surg; 2014 Nov; 149(11):1113-20. PubMed ID: 25188466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.
    Hawn MT; Graham LA; Richman JS; Itani KM; Henderson WG; Maddox TM
    JAMA; 2013 Oct; 310(14):1462-72. PubMed ID: 24101118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry.
    Berger PB; Kleiman NS; Pencina MJ; Hsieh WH; Steinhubl SR; Jeremias A; Sonel A; Browne K; Barseness G; Cohen DJ;
    JACC Cardiovasc Interv; 2010 Sep; 3(9):920-7. PubMed ID: 20850090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents.
    van Kuijk JP; Flu WJ; Schouten O; Hoeks SE; Schenkeveld L; de Jaegere PP; Bax JJ; van Domburg RT; Serruys PW; Poldermans D
    Am J Cardiol; 2009 Nov; 104(9):1229-34. PubMed ID: 19840567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Coronary Stent Indication With Postoperative Outcomes Following Noncardiac Surgery.
    Holcomb CN; Hollis RH; Graham LA; Richman JS; Valle JA; Itani KM; Maddox TM; Hawn MT
    JAMA Surg; 2016 May; 151(5):462-9. PubMed ID: 26720292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
    Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
    Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study.
    Wijeysundera DN; Wijeysundera HC; Yun L; Wąsowicz M; Beattie WS; Velianou JL; Ko DT
    Circulation; 2012 Sep; 126(11):1355-62. PubMed ID: 22893606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.
    Rabbitts JA; Nuttall GA; Brown MJ; Hanson AC; Oliver WC; Holmes DR; Rihal CS
    Anesthesiology; 2008 Oct; 109(4):596-604. PubMed ID: 18813037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and timing of noncardiac surgery after cardiac stent implantation.
    Hawn MT; Graham LA; Richman JR; Itani KM; Plomondon ME; Altom LK; Henderson WG; Bryson CL; Maddox TM
    J Am Coll Surg; 2012 Apr; 214(4):658-66; discussion 666-7. PubMed ID: 22341201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary stents and subsequent surgery: reported provider attitudes and practice patterns.
    Graham LA; Maddox TM; Itani KM; Hawn MT
    Am Surg; 2013 May; 79(5):514-23. PubMed ID: 23635588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review.
    Childers CP; Maggard-Gibbons M; Ulloa JG; MacQueen IT; Miake-Lye IM; Shanman R; Mak S; Beroes JM; Shekelle PG
    Syst Rev; 2018 Jan; 7(1):4. PubMed ID: 29321066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
    Armstrong EJ; Graham L; Waldo SW; Valle JA; Maddox TM; Hawn MT
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):617-627. PubMed ID: 27315550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
    Jones DA; Rathod KS; Gallagher S; Weerackody R; Knight CJ; Rothman MT; Mathur A; Jain AK; Timmis AD; Wragg A
    Catheter Cardiovasc Interv; 2013 May; 81(6):E237-44. PubMed ID: 22707383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative complications after noncardiac surgery in patients with insertion of second-generation drug-eluting stents.
    Lo N; Kotsia A; Christopoulos G; Roesle M; Rangan BV; Kim BJ; Webb A; Banerjee S; Brilakis ES
    Am J Cardiol; 2014 Jul; 114(2):230-5. PubMed ID: 24878120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.
    Aggarwal V; Stanislawski MA; Maddox TM; Nallamothu BK; Grunwald G; Adams JC; Ho PM; Rao SV; Casserly IP; Rumsfeld JS; Brilakis ES; Tsai TT
    J Am Coll Cardiol; 2014 Oct; 64(17):1825-36. PubMed ID: 25443706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.